Clinical Trial

Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is being conducted to evaluate the efficacy, and safety of SHR-A1811 in advanced colorectal cancer subjects.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-08; most recent amendment 2025-07-16.
Status change: Recruiting → Active, Not Recruiting 2025-07-16
Status change: Not Yet Recruiting → Recruiting 2024-03-13
Trial Details
NCT Number NCT06199973
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Advanced Colorectal Cancer
Enrollment 130 participants
Start Date 2024-03-01
Primary Completion 2026-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-17